AU8102398A - (dl)-2,3-diaryl-2h-1-benzopyrans - Google Patents

(dl)-2,3-diaryl-2h-1-benzopyrans

Info

Publication number
AU8102398A
AU8102398A AU81023/98A AU8102398A AU8102398A AU 8102398 A AU8102398 A AU 8102398A AU 81023/98 A AU81023/98 A AU 81023/98A AU 8102398 A AU8102398 A AU 8102398A AU 8102398 A AU8102398 A AU 8102398A
Authority
AU
Australia
Prior art keywords
benzopyrans
diaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU81023/98A
Inventor
Janak Dulari Dhar
Kanchan Hajela
Virender Mohan Labroo
Jaya Pandey
Suprabhat Ray
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Central Drug Research Institute
Original Assignee
Novo Nordisk AS
Central Drug Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS, Central Drug Research Institute filed Critical Novo Nordisk AS
Publication of AU8102398A publication Critical patent/AU8102398A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU81023/98A 1997-07-09 1998-07-02 (dl)-2,3-diaryl-2h-1-benzopyrans Abandoned AU8102398A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5202297P 1997-07-09 1997-07-09
US60052022 1997-07-09
DK92297 1997-08-11
DK922/97 1997-08-11
PCT/DK1998/000301 WO1999002512A1 (en) 1997-07-09 1998-07-02 Dl-2,3-diaryl-2h-1-benzopyrans

Publications (1)

Publication Number Publication Date
AU8102398A true AU8102398A (en) 1999-02-08

Family

ID=26064911

Family Applications (1)

Application Number Title Priority Date Filing Date
AU81023/98A Abandoned AU8102398A (en) 1997-07-09 1998-07-02 (dl)-2,3-diaryl-2h-1-benzopyrans

Country Status (2)

Country Link
AU (1) AU8102398A (en)
WO (1) WO1999002512A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2188222T3 (en) * 1998-08-14 2003-06-16 Schering Corp ENANTIOSELECTIVE SYNTHESIS.
HU230543B1 (en) 1999-07-06 2016-11-28 Endorecherche, Inc. Medicament useful for treating and/or suppressing weight gain
DE10013782A1 (en) 2000-03-15 2001-10-18 Schering Ag 4-fluoroalkyl-2H-benzopyrans with antiestrogenic activity, process for their preparation, pharmaceutical preparations containing them and their use in the manufacture of medicaments
WO2003044006A1 (en) * 2001-11-19 2003-05-30 Eli Lilly And Company Substituted benzopyrans as selective estrogen receptor-beta agonists
EP1790644A1 (en) * 2001-11-19 2007-05-30 Eli Lilly And Company Substituted benzopyrans as selective estrogen receptor-beta agonists
US6630508B1 (en) 2002-02-11 2003-10-07 Eli Lilly And Company Substituted benzopyrans as selective estrogen receptor β agonists
SI1626974T1 (en) 2003-04-21 2009-02-28 Lilly Co Eli Substituted benzopyrans as selective estrogen receptor-beta agonists
EP1618102B1 (en) 2003-04-21 2010-02-10 Eli Lilly And Company Substituted benzopyrans as selective estrogen receptor-beta agonists
EP2580210B1 (en) 2010-06-10 2017-03-01 Seragon Pharmaceuticals, Inc. Estrogen receptor modulators and uses thereof
US8853423B2 (en) 2010-06-17 2014-10-07 Seragon Pharmaceuticals, Inc. Indane estrogen receptor modulators and uses thereof
US9187460B2 (en) 2011-12-14 2015-11-17 Seragon Pharmaceuticals, Inc. Estrogen receptor modulators and uses thereof
MD20140054A2 (en) 2011-12-16 2014-10-31 Olema Pharmaceuticals, Inc. Novel benzopyran compounds, compositions and uses thereof
IL283559B (en) 2015-10-27 2022-07-01 Sun Pharma Advanced Res Co Ltd Novel heterocyclic antiestrogens
WO2021014386A1 (en) 2019-07-22 2021-01-28 Sun Pharma Advanced Research Company Limited Selective estrogen receptor degrader

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
US5254568A (en) * 1990-08-09 1993-10-19 Council Of Scientific & Industrial Research Benzopyrans as antiestrogenic agents
US6060503A (en) * 1991-12-02 2000-05-09 Endorecherche, Inc. Benzopyran-containing compounds and method for their use

Also Published As

Publication number Publication date
WO1999002512A1 (en) 1999-01-21

Similar Documents

Publication Publication Date Title
AU1709299A (en) Mixer-injectors
AU1009797A (en) 2-oxo- and 2-thio-1,2-dihydroquinolinyl-oxazolidinones
AU6720798A (en) 2-arylcyclopentan-1,3-diones
AU6856698A (en) High-molecular polyamide
AU6399798A (en) New catalysts
AU6598798A (en) Resorcinyl-triazines
AU2681895A (en) 8-aryl-1,6-naphthyridin-5-ones
AU1027499A (en) 32P-polyphosphazene
AU9513298A (en) Fluoranthenopyrans
AU8102398A (en) (dl)-2,3-diaryl-2h-1-benzopyrans
AU9750398A (en) D-homo-9,10-secocholesta-23-yne-3,25-diol derivatives
AU9066598A (en) Substituted 4-benzoyl-pyrazoles
AU5272198A (en) EMP-charge-eliminator
DE59804842D1 (en) Aliphatische, emissionsarme, sinterfähige thermoplastische polyurethanformmassen
AU9156198A (en) 2-benzoyl-cyclohexane-1,3-diones
AU4720397A (en) Terpenylated diketopiperazines, (drimentines)
AU4117497A (en) Micropolarimeter
AU6998698A (en) Dioxacycloalkan-8-one
AU7570296A (en) 25-hydroxy-16-ene-26,27-bishomo-cholecalciferols
AU6185898A (en) Clavaspirins
AU6525998A (en) Improved metallo-endopeptidases
AU2000299A (en) Semaphorin zsmf-3
AU6090898A (en) Substituted 4-benzoyl-pyrazoles
AU6423298A (en) 4-arylmethylene-1,4-dihydro-2h-azine derivatives
AU1558200A (en) 1-hydroxy-3-sulfonoalkane-1,1-diphosphonous acids

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase